Condition
Fatty Acids
Total Trials
6
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 3 (1)
Trial Status
Completed4
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04743050Phase 3UnknownPrimary
The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases.
NCT03572205Not ApplicableCompletedPrimary
Fatty Acid Desaturase Gene Locus Interactions With Diet (FADSDIET2)
NCT01692951Completed
Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer
NCT03170973Not ApplicableUnknown
Influence of Exercise on Trans Fatty Acids
NCT02062528Not ApplicableCompleted
Hot Flashes and Omega 3
NCT02259153Not ApplicableCompleted
Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis
Showing all 6 trials